BCA
CELG

Berman Capital Advisors’s Celgene Corp CELG Stock Holding History

Berman Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,152
Closed -$114K – 1630
2019
Q3 		$114K Buy
1,152
+56
+5% +$5.32K 0.04% 198
2019
Q2 		$101K Buy
1,096
+111
+11% +$10.5K 0.03% 207
2019
Q1 		$92K Buy
985
+464
+89% +$40.6K 0.03% 204
2018
Q4 		$32K Buy
+521
New +$38.5K 0.01% 308

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Berman Capital Advisors's CELG Position: Q4 2019 in Review

Berman Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,152 shares — an estimated $114K sold.

Berman Capital Advisors first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $114K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Berman Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Berman Capital Advisors sold 1,152 Celgene Corp shares in Q4 2019, an estimated $114K.
  • Berman Capital Advisors first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Berman Capital Advisors's Celgene Corp position peaked at $114K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Berman Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.